Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids

Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids

Abstract Background Patient-derived organoids (PDO) have been proposed as a novel in vitro method of drug screening for different types of cancer. However, to date, extrahepatic biliary tract carcinoma (eBTC) PDOs have not yet been fully established. Methods We collected six samples of gallbladder c...

Full description

Bibliographic Details
Main Authors: Zhiwei Wang, Yinghao Guo, Yun Jin, Xiaoxiao Zhang, Hao Geng, Guangyuan Xie, Dan Ye, Yuanquan Yu, Daren Liu, Donger Zhou, Baizhou Li, Yan Luo, Shuyou Peng, Jiangtao Li
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Cancer Cell International
Subjects:
Extrahepatic biliary tract carcinoma
Organoids
Pathological staining
Genetic profiles
Drug screening
Online Access:https://doi.org/10.1186/s12935-021-02219-w

Internet

https://doi.org/10.1186/s12935-021-02219-w

Similar Items